CervoMed
CRVO
11 hedge funds and large institutions have $590K invested in CervoMed in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0.83% less ownership
Funds ownership: 6.6% → 5.78% (-0.83%)
8% less funds holding
Funds holding: 12 → 11 (-1)
30% less capital invested
Capital invested by funds: $839K → $590K (-$249K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$4.65K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$77.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.52K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.59K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$76 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $221K | -$25.3K | -4,354 | -9% |
|
|
2
Renaissance Technologies
New York
| $135K | +$4.65K | +800 | +3% |
|
3
BlackRock
New York
| $110K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $56.8K | – | – | – |
|
|
BCM
5
Bridgeway Capital Management
Houston,
Texas
| $55K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $8.05K | -$3.52K | -606 | -27% |
|
|
7
Osaic Holdings
Scottsdale,
Arizona
| $1.98K | -$76 | -13 | -3% |
|
8
Morgan Stanley
New York
| $1.83K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $200 | -$1.59K | -273 | -87% |
|
|
10
Wells Fargo
San Francisco,
California
| $50 | +$6 | +1 | +11% |
|
|
TF
11
TimeScale Financial
Danvers,
Massachusetts
| $30 | – | – | – |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$77.6K | -12,438 | Closed |
|
CRVO Hedge Fund Activity: Q2 2023 in Review
11 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2023, worth a combined $590K — down 30% from $839K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CRVO and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $4.65K. The largest seller was Citadel Advisors, exiting entirely with an estimated $77.6K sold.
- 11 institutional investors held CervoMed (CRVO) as of Q2 2023, down from 12 in Q1 2023.
- Funds reported $590K of CervoMed stock for Q2 2023, down 30% quarter-over-quarter.
- 0 funds opened new CervoMed positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest CervoMed buyer in Q2 2023 was Renaissance Technologies, an estimated $4.65K added.
- The largest CervoMed seller in Q2 2023 was Citadel Advisors, an estimated $77.6K sold.
Based on aggregated 13F filings for Q2 2023.